Proniras Corporation
PrivateLast Round
Series B
Feb 1, 2024
Total Funding Raised
$21.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proniras Corporation Comparables
Compare Proniras Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aether Therapeutics | 80% | |
| Kinoxis Therapeutics | 77% | |
| BioCorRx Inc | 73% |
Proniras Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 1, 2024 | ||||
| Grant | Sep 17, 2020 | ||||
| Series A | Jul 12, 2019 | ||||
| Accelerator | Apr 27, 2018 |
Key People
Founding team and executive leadership
Proniras Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series B, Accelerator |
| ARCH Venture Partners | Accelerator, Series B |
| WRF Capital | Series B, Accelerator |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| ARCH Venture Partners | Accelerator, Series B |
| Washington Research Foundation Capital | Series B, Accelerator |
| Alexandria Venture Investments | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 32% MoM.
- Sep 17, 2020
$12M grant awarded by the National Institute on Drug Abuse.
Proniras Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Proniras Corporation's valuation, stock price, and market status.
Is Proniras Corporation a public or private company?
Proniras Corporation is a private company.
What is the current stock price of Proniras Corporation?
Proniras Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is Proniras Corporation worth (valuation)?
Valuation information for Proniras Corporation is not publicly available.
Can I buy Proniras Corporation stock?
Proniras Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Proniras Corporation's last funding round?
Proniras Corporation's most recent funding round was Series B on February 1, 2024.
Who are the main investors in Proniras Corporation?
Key investors in Proniras Corporation include Accelerator Life Science Partners, ARCH Venture Partners.
Will Proniras Corporation IPO soon?
No public IPO plans have been announced for Proniras Corporation.
How can I track Proniras Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proniras Corporation's secondary market activity and sign up for updates.